0
Editor's Correspondence |

Is There Enough Evidence That Low-Molecular-Weight Heparin Is Superior to Unfractionated Heparin in Pulmonary Embolism?—Reply

Russell D. Hull, MBBS, MSC; Gary E. Raskob, PhD; Rollin F. Brant, PhD; Graham F. Pineo, MD; Paul D. Stein, MD; Andrew F. Mah, BSC
Arch Intern Med. 2000;160(13):2061-2067. doi:.
Text Size: A A A
Published online

Extract

In reply

In response to Sharma's comment that subtherapy may be a confounder in the intravenous heparin arm of our study, we administered heparin by a protocol that achieved high rates of successful therapy, and most patients receiving warfarin sodium achieved therapeutic international normalized ratios (INRs). There was a similar low frequency of subtherapeutic INRs during long-term therapy in both treatment groups. The only difference between the 2 treatment groups with regard to subtherapeutic monitoring and recurrent venous thromboembolism occurred in one patient with subtherapeutic activated partial thromboplastin times in the unfractionated heparin group. The necessity for anticoagulant monitoring to achieve therapeutic levels is a practical limitation of unfractionated heparin therapy. The advantage of low-molecular-weight heparin (LMWH) is that the required dosage is predicted by body weight, and anticoagulant monitoring is not required. Our findings demonstrate that the regimen of LMWH used was superior to protocol-driven unfractionated intravenous heparin. In the absence of a heparin protocol, many more patients receiving intravenous unfractionated heparin would have had subtherapeutic levels.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
/>
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Jobs
JAMAevidence.com

Users' Guides to the Medical Literature
Thromboembolism or Acute Pulmonary Embolism

Users' Guides to the Medical Literature
Table 9.2-3 Refuted Evidence From Observational Studiesa

brightcove.createExperiences();